Ayala Pharma
IPO News: Filed S-1/A: Ayala Pharmaceuticals Launches ~3.3mm Share Offering IPO with $14-$16 Marketing Range
Ayala Pharma

Ayala Pharmaceuticals

Nasdaq:  AYLA

Initial Filing Date:  03/06/20

Launch Date:  05/04/20

Price Range:  $14.00 - $16.00

Shares Offered (Pre-Shoe | mm):  3.3

Primary Shares (mm):  3.3

Secondary Shares (mm):  0.0

Amount Offered (@ Midpoint)(mm):  $50.0

% Secondary:  0.0%

Shares Outstanding (mm):  12.1

Market Value at Midpoint (mm):  $181.7

Offering as % of Market Value:  27.5%

Bookrunners:  Citi | Jefferies

Co-Managers:  Oppenheimer | Raymond James

Major Holders:  Israel Biotech Fund | aMoon | Harel Insurance Co. | Bristol-Meyers Squibb | Novartis Institutes

Description:  Ayala is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations.

Note:  Emerging Growth Company

 

Reference Link:  S-1/A